德龙汇能集团股份有限公司 DELONG COMPOSITE ENERGY GROUP CO., LTD 募集资金管理办法 ［本制度尚需提交公司 2025 年第三次临时股东大会审议］ 第一章 总则 第一条 为了规范德龙汇能集团股份有限公司（以下简称 "公司"）募集资金的管理和运用，切实保护投资者的利益， 依据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司募集资金监管规则》《深圳证券交易所股票上市规则》《深 圳证券交易所主板上市公司规范运作指引》等法律、法规及规 范性文件的规定，结合公司实际情况，制定本办法。 第二条 本办法所称募集资金是指公司通过发行证券股 票或者其他具有股权性质的证券，向投资者募集并用于特定 用途的资金，不包括公司为实施股权激励计划募集的资金。 本办法所称超募资金，是指实际募集资金净额超过计划 募集资金金额的部分 第三条 公司募集资金应当专款专用。公司使用募集资金应 当符合国家产业政策和相关法律法规，践行可持续发展理念，履 行社会责任，原则上应当用于主营业务，有利于增强公司竞争能 力和创新能力。 第四条 公司应当审慎使用募集资金，保证募集资金 的使用与发行申请文件的承诺相一致，不 ...

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the actual usage of the raised funds by Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. for the first half of 2025, ensuring compliance with regulatory requirements and transparency in financial management. Group 1: Fundraising Overview - The company raised a total of approximately 7.89 billion RMB through a non-public offering of 334,711,699 shares at a price of 23.56 RMB per share, with a net amount of approximately 7.86 billion RMB after deducting issuance costs [1][2]. - The funds were verified by an accounting firm, and the report includes a verification report number [1]. Group 2: Fund Usage and Current Balance - As of June 30, 2025, the total amount of raised funds used was approximately 766,170.29 million RMB, with a remaining balance of approximately 41,839.21 million RMB in dedicated accounts [2][3]. - The company has established dedicated accounts at various banks to manage the raised funds, ensuring proper oversight and compliance with regulations [3][4]. Group 3: Fund Management and Compliance - The company has implemented a fundraising management method to regulate the use of raised funds and protect investor interests, which was approved by the shareholders [2][4]. - There were no instances of using idle funds for temporary working capital or investing in financial products during the reporting period [6][12]. Group 4: Project Investment and Changes - The total investment in fundraising projects amounted to approximately 766,170.29 million RMB, including pre-investments from self-raised funds [6][10]. - The company has made changes to the use of funds for specific projects, including reallocating funds for the acquisition of trademarks and construction projects, with all changes approved by the board and disclosed appropriately [8][9][10]. Group 5: Project Status and Future Plans - Several projects funded by the raised capital are either completed or in the operational phase, with ongoing assessments of their financial returns [12][14]. - The company has not reported any significant delays or changes in the feasibility of the projects funded by the raised capital [12][14].

Core Points - The document outlines the fundraising management system of Guangzhou Weili Medical Equipment Co., Ltd, aiming to regulate the use and management of raised funds, enhance efficiency, and protect investors' rights [1][2][3] Group 1: General Principles - The system applies to funds raised through stock issuance or other equity-like securities, excluding funds raised for equity incentive plans [1] - Funds must be used specifically for designated purposes, aligning with national industrial policies and sustainable development principles [1][2] - The board of directors is responsible for monitoring the management and usage of raised funds to mitigate investment risks [2][3] Group 2: Fund Storage - The company must open a special account for raised funds in a commercial bank, ensuring that these funds are not mixed with other funds [9][10] - If the company has multiple financings, separate accounts must be established for each [10] - A tripartite supervision agreement must be signed with the underwriter or independent financial advisor and the bank within one month of fund receipt [12][13] Group 3: Fund Usage - Funds must be used according to the usage plan outlined in the issuance application documents [13][14] - If significant changes occur affecting the investment project, the company must reassess the project's feasibility and disclose any adjustments [14][15] - The company is prohibited from using raised funds for financial investments or providing funds to controlling shareholders or related parties [6][7] Group 4: Changes in Fund Allocation - Any changes in the use of raised funds require board approval and must be disclosed to shareholders [32][33] - The company must ensure that new investment projects enhance competitiveness and innovation capabilities [34][35] - If funds are to be used for projects outside the original plan, a detailed disclosure of reasons and implications is required [36][37] Group 5: Management and Supervision - The finance department must maintain a detailed record of fund usage, and internal audits should occur at least biannually [38][39] - The underwriter or independent financial advisor must conduct regular oversight and report any irregularities [40][41] - Annual audits must include a verification report on the management and usage of raised funds [42][43]

Core Points - The company establishes a system to improve the management and usage of raised funds, ensuring compliance with relevant laws and regulations [1][2][3] - The company must disclose the actual usage of raised funds accurately and completely, and announce any significant impacts on investment plans [2][3] - The company is prohibited from changing the intended use of raised funds without proper approval and disclosure [3][4] Fund Management - The company must establish internal controls for the management and usage of raised funds, including approval processes and risk control measures [2][5] - Raised funds should be stored in a special account approved by the board and cannot be used for non-designated purposes [9][10] - The company can temporarily use idle raised funds for cash management, provided it does not affect the normal investment plans [6][7] Investment Projects - The company must use raised funds for specific projects as outlined in the prospectus and cannot change the project without board approval [3][4] - If there are changes in the investment project, the company must provide justifications and seek necessary approvals [11][12] - The company is required to report on the progress of investment projects and any deviations from the planned usage of raised funds [13][14] Oversight and Reporting - The company must conduct regular audits of the management and usage of raised funds and report findings to the board [5][13] - The sponsor institution is responsible for ongoing supervision of the company's fund management and must report any irregularities [13][14] - The company must disclose any significant changes in the financial status of cash management products used for idle funds [7][8]

Meeting Overview - The second meeting of the Supervisory Board of Shanghai Huhui Optoelectronics Co., Ltd. was held on August 14, 2025, with all 7 supervisors present, confirming the legality and validity of the meeting procedures [1] - The meeting was chaired by Mr. Ying Xiaoming, and the notice was sent to all supervisors on August 4, 2025 [1] Financial Reporting - The preparation and review process of the 2025 semi-annual report complies with relevant laws and regulations, accurately reflecting the company's financial status and operational results [1] - The report contains no false records, misleading statements, or significant omissions [1] Fund Management - The management and actual use of raised funds for the first half of 2025 comply with legal regulations, with no violations or misappropriations reported [2] - The special report on the management and use of raised funds accurately reflects the actual situation [2] Fund Replacement - The company plans to use its own funds to pay for project investments and will subsequently replace them with raised funds, which is in line with regulatory requirements [3] - This approach aims to enhance operational management efficiency without harming shareholder interests [3] Cash Management - The company intends to use a maximum of RMB 300 million of temporarily idle raised funds for cash management within 12 months, ensuring it does not conflict with investment project implementations [4] - This decision is expected to improve fund utilization efficiency and yield good returns [4] Supervisory Board Changes - The company plans to abolish the Supervisory Board, transferring its powers to the Audit Committee of the Board of Directors, pending shareholder approval [5] - Corresponding amendments to the company's articles of association and meeting rules have been drafted [5]

Group 1 - The board of directors of Wuhan Guangting Information Technology Co., Ltd. held its seventh meeting of the fourth session on August 15, 2025, with all nine directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the "2025 Semi-Annual Report" and its summary, confirming that the report accurately reflects the company's financial status and operational results without any false statements or omissions [2][3] - The board also approved the "Special Report on the Storage and Use of Raised Funds for the First Half of 2025," affirming that the disclosure of the use of raised funds aligns with actual usage and complies with relevant regulations [2][3] Group 2 - The board agreed to use up to RMB 900 million of temporarily idle raised funds for cash management, ensuring that this does not affect the investment projects or normal operations, with a validity period of 12 months [3]

Meeting Overview - The seventh meeting of the fourth Supervisory Board of Wuhan Guangting Information Technology Co., Ltd. was held on August 15, 2025, with all three supervisors present, including one via telecommunication [1] - The meeting was convened and chaired by the chairman of the Supervisory Board, Dong Yong, and complied with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board approved the proposal regarding the full text and summary of the 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or omissions [1][2] - The board also approved the special report on the storage and use of raised funds for the first half of 2025, affirming that the usage complies with relevant laws and accurately discloses the specific usage of the funds [2] - Additionally, the board agreed to use idle raised funds for cash management, which is expected to enhance the efficiency of fund usage and provide better returns for shareholders, while ensuring it does not affect project progress or normal operations [2][3]

Core Viewpoint - The company has approved the use of its own funds to pay for fundraising investment projects and will subsequently replace these with the raised funds, ensuring compliance with regulatory requirements and optimizing fund usage efficiency [1][4][5]. Summary of Fundraising Situation - The company issued convertible bonds with a total face value of 1,435.01 million yuan, with a net amount raised of 1,421.31 million yuan after deducting related fees [1][2]. - The total investment amount for the projects is 2,514.61 million yuan, with 1,425.00 million yuan planned to be funded by the raised funds [2]. Reasons for Using Own Funds - The company needs to use its own funds initially due to regulatory requirements regarding salary payments and the management of fundraising accounts, which complicates direct payments from the fundraising account [3][4]. Operational Process for Fund Replacement - The company will pay with its own funds and then replace these with raised funds within six months, ensuring proper documentation and compliance with internal approval processes [3][4]. Impact on the Company - This approach is expected to enhance the efficiency of fund usage and project implementation without altering the intended use of the raised funds or harming shareholder interests [4][5]. Review Procedures - The board and supervisory committee have approved the proposal, and the company has followed necessary decision-making processes, not requiring shareholder meeting approval [4][5]. Opinions from Supervisory Committee and Sponsor - The supervisory committee supports the decision, stating it will improve fund efficiency and safeguard shareholder interests [5][6]. - The sponsor has confirmed that the process complies with relevant regulations and does not affect the normal implementation of fundraising projects [5][6].

Fundraising Overview - The company raised a total of RMB 2,176.72 million through its initial public offering, with a net amount confirmed by an audit report [1] - The company issued convertible bonds with a total face value of RMB 1,435.01 million, resulting in a net amount of RMB 1,421.31 million after deducting related fees [2] Fund Utilization and Balance - As of June 30, 2025, the company had a balance of RMB 256.29 million in its fundraising account, with actual interest income of RMB 1.45 million during the reporting period [2][3] - Cumulative interest income, net of fees, amounted to RMB 75.95 million, with RMB 3.77 million received from financial investments [2][3] Fund Management - The company has established a dedicated management system for fundraising, ensuring compliance with relevant regulations and maintaining a special account for fund storage [3][4] - A tripartite supervision agreement has been signed with banks and sponsors to oversee the management of the fundraising [4] Investment Projects - The company has not made any pre-investments or replacements for fundraising projects during the reporting period [5] - There were no instances of using idle funds to temporarily supplement working capital [5] Cash Management - The company approved the use of up to RMB 600 million of temporarily idle funds for cash management, focusing on low-risk financial products [5] - As of June 30, 2025, the balance of funds under cash management was RMB 0 million [5][6] Project Progress - The company reported that all fundraising projects are progressing as planned, with no changes in project funding usage [6] - Specific projects, such as the new detector and scintillator material industrialization, are on track according to the schedule [6]

Core Viewpoint - The company intends to use its own funds to pay for investment projects and subsequently replace these funds with the raised capital, ensuring compliance with regulatory requirements and optimizing fund usage efficiency [1][6][7] Fundraising Overview - The company raised a total of RMB 1,435.01 million through the issuance of convertible bonds, with a net amount of RMB 1,421.31 million after deducting issuance costs [1] - The funds have been fully received and verified by an accounting firm [1] Investment Project Details - The raised funds are allocated to specific projects, including the industrialization of new detectors and scintillator materials, with a total investment of RMB 2,514.61 million [3] - As of the latest report, 87.55% of the total investment has been completed using the raised funds [3] Reasons for Using Own Funds - The company has opted to use its own funds for initial payments due to regulatory requirements regarding salary payments and the need for efficient fund management [4][5] - This approach allows for better compliance with banking regulations and simplifies the management of project-related expenses [4] Operational Process for Fund Replacement - The company will replace the funds used from its own account with the raised funds within six months, ensuring proper documentation and compliance with regulatory oversight [5] Impact on the Company - The decision to use own funds for project payments is expected to enhance the efficiency of fund usage and project implementation without altering the intended use of the raised funds [6] - The company has confirmed that this action does not harm the interests of shareholders, particularly minority shareholders [6] Approval Process - The board of directors and the supervisory board have reviewed and approved the proposal to use own funds for project payments, confirming adherence to necessary decision-making procedures [6][7]